Human Primary Breast Cancer Organoid

Description

Human breast cancer organoid are patient-derived 3D tumor models that preserve the histological and molecular features of primary breast tumors. They provide clinically relevant platforms for understanding tumor mechanisms, biomarker analysis, and therapeutic response. Cultured in multiwell plates, these organoids can be integrated into automated high-throughput drug screening workflows, enabling large-scale compound library testing to identify lead candidates. Automated imaging and quantitative analysis, combined with immunofluorescence staining and confocal microscopy, further support precise evaluation of phenotypic changes, biomarker expression, and dose-dependent drug responses.